PHARMACEUTICAL COMPOSITION FOR ALLERGIC AND INFLAMMATORY SKIN DISEASES Russian patent published in 2012 - IPC A61K31/00 A61K31/4178 A61K31/4725 A61K31/57 A61P31/10 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine and pharmaceutical industry. A pharmaceutical composition for outward application for treating allergic and inflammatory skin diseases contains a glucocorticosteroid specified in a group: mometasone or its derivatives, betametasone or its derivatives, beclometasone or its derivatives, dexametasone or its derivatives, flumetasone or its derivatives; as an antibacterial quinolone compound, it contains a compound specified in a group: ofloxacin, lomefloxacin, norfloxacin, pefloxacin, ciprofloxacin, levofloxacin, sparfloxacin, moxifloxacin; as an antifungal azol compound, it contains a compound specified in a group: clotrimazole, ketoconazole, myconazole, fluconazole, itraconazole, voriconazole and additionally contains a synthetic polymeric high-molecular compound, particularly polyvinyl pyrrolidone, or polymers or copolymers of acrylic and metacrylic acid, or polyvinyl alcohol, or siloxane or silane polymers in certain proportions.

EFFECT: invention provides higher effectiveness in inflammatory and allergic skin diseases with no side reactions and systemic exposure.

2 tbl, 80 ex, 3 dwg